Mainboard · BSE and NSEDraft filed
VARDAAN BIOTECH LIMITED IPO: dates, price band, lot size, objects of the issue
Get updates on this IPO
Dates, price band, allotment and listing notices by email, and new views from SEBI-registered research analysts on InsightPier by email.Dates, allotment, listing and analyst views. Stop anytime.
By continuing you agree to the Terms and Privacy policy
Key facts
- Price band
- Not announced
- Lot size
- Not announced
- Lot amount at the upper band
- Not announced
- Issue size at the upper band
- 3,50,00,000 shares (Amount not stated in the draft)
- DRHP dated Fri 18 Sep 2026, page 1
- Bid dates
- Not announced
- Listing date
- Not announced
- Risk factors
- Not announced
- Proposed exchanges
- BSE and NSE
Timeline (IST)
- Draft filedTue 22 Sep 2026 confirmedDRHP dated Fri 18 Sep 2026
- OpensDates to be announced
- ClosesDates to be announced
- AllotmentDates to be announced
- Refund and unblockDates to be announced
- ListingDates to be announced
Company and promoters
As described in the DRHP
We are an integrated seed company engaged in the development, breeding, production, processing, conditioning, of agricultural seeds across multiple crop varieties.
DRHP dated Fri 18 Sep 2026, page 179
Promoters
- 2 individual promoters
DRHP dated Fri 18 Sep 2026, page 240
Shareholding
| Holding | Before the issue | After the issue |
|---|---|---|
| Promoters and promoter group | 71.96% | Not stated in the DRHP |
DRHP dated Fri 18 Sep 2026, page 93
Financials (restated)
| Item | March 31, 2026 | March 31, 2025 | March 31, 2024 |
|---|---|---|---|
| Revenue from operations | ₹167.09 crore | ₹151.13 crore | ₹140.14 crore |
| Profit after tax | ₹18.35 crore | ₹17.61 crore | ₹16.48 crore |
| Net worth | ₹99.55 crore | ₹61.00 crore | ₹43.37 crore |
| Total borrowings | Not stated in the draft | Not stated in the draft | Not stated in the draft |
DRHP dated Fri 18 Sep 2026, page 67
Peer comparison (as in the DRHP)
| Companies | CMP (₹) | EPS (₹) | PE Ration | RONW (%) | NAV (Per Share) (₹) | Face Value (₹) | Revenue from Operation (₹ in Lakhs) | Other Income (₹ in Lakhs) | Total Income (₹ in Lakhs) |
|---|---|---|---|---|---|---|---|---|---|
| Vardaan Biotech Limited | [●] | 12.53 | [●] | 18.43 | 56.77 | 10 | 16,709.37 | 18.82 | 16,728.19 |
| Nath Bio-Genes (India) Ltd | 153.93 | 20.98 | 7.99 | 6.12 | 385.06 | 10.00 | 44,510.15 | 781.00 | 45,291.15 |
| Indo US Bio-Tech Ltd | 85.96 | 6.54 | 14.21 | 14.18 | 46.15 | 10.00 | 11,043.91 | 5.42 | 11,049.33 |
| Bombay Super Hybrid Seeds Ltd | 88.07 | 2.54 | 33.20 | 20.35 | 12.49 | 1.00 | 34,408.44 | 87.6 | 34,496.04 |
| Kaveri Seed Company Limited | 773.40 | 56.94 | 15.44 | 16.86 | 341.06 | 2.00 | 1,39,476.26 | 2930.33 | 1,42,406.59 |
Reproduced from the DRHP dated Fri 18 Sep 2026, page 121; InsightPier adds no figures
Risk factors
- A promoter faces a pending criminal case and investigation by the Economic Offences Wing (DRHP page 27)
- Weather, crop disease and pests can hurt operations and finances (DRHP page 27)
- Revenue depends heavily on a few seed products, mainly maize, paddy and wheat seeds (DRHP page 28)
- Procurement is concentrated in Telangana, Madhya Pradesh and Gujarat (DRHP page 29)
- Revenue is concentrated in a few states, mainly Madhya Pradesh and Maharashtra (DRHP page 30)